[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f2mwrnbrn0itac":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":47,"exclusivities":48,"paragraphIv":49,"catalysts":51},"ARIXTRA","FONDAPARINUX SODIUM","MYLAN IRELAND LTD","mylan-ireland-ltd",[20],"021345","none",4,0,[25,34,39,43],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021345-001","001","SOLUTION","SUBCUTANEOUS","2.5MG\u002F0.5ML (2.5MG\u002F0.5ML)","2001-12-07","AP","RX",{"key":35,"applNo":20,"productNo":36,"dosageForm":28,"route":29,"strength":37,"approvalDate":38,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021345-002","002","5MG\u002F0.4ML (5MG\u002F0.4ML)","2004-05-28",{"key":40,"applNo":20,"productNo":41,"dosageForm":28,"route":29,"strength":42,"approvalDate":38,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021345-003","003","7.5MG\u002F0.6ML (7.5MG\u002F0.6ML)",{"key":44,"applNo":20,"productNo":45,"dosageForm":28,"route":29,"strength":46,"approvalDate":38,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021345-004","004","10MG\u002F0.8ML (10MG\u002F0.8ML)",[],[],{"asOf":12,"firstFiled":12,"entries":50},[],[]]